DIABETIC NEPHROPATHY - CAN IT BE PREVENTED - ARE THERE RENAL PROTECTIVE ANTIHYPERTENSIVE DRUGS OF CHOICE

被引：7

作者：

BAUER, JH ^{[1
]}

机构：

[1] HARRY S TRUMAN MEM VET HOSP, MED SERV, COLUMBIA, MO 65201 USA

来源：

SOUTHERN MEDICAL JOURNAL | 1994年 / 87卷 / 10期

关键词：

D O I：

10.1097/00007611-199410000-00017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic nephropathy is the most common cause of end-stage renal disease in the United States. This review focuses on (1) the problem of diabetic nephropathy, (2) hypertension in patients with diabetes mellitus, (3) the pathophysiology of diabetic nephropathy, and (4) therapeutic methods designed to provide renal protection to patients with diabetes mellitus. The treatments discussed are (1) strict metabolic control, (2) strict control of systemic hypertension, (3) control of glomerular hypertension, and (4) dietary protein restriction. Diabetic nephropathy can be retarded; renal protection depends primarily on strict metabolic control and strict control of systemic hypertension. With respect to the kidney, there are no unique renal protective antihypertensive drugs of choice.

引用

页码：1043 / 1053

页数：11

共 111 条

[21] EFFECTS OF NIFEDIPINE AND ENALAPRIL ON GLOMERULAR STRUCTURE AND FUNCTION IN UNINEPHRECTOMIZED SHR [J].

DWORKIN, LD ;

FEINER, HD ;

PARKER, M ;

TOLBERT, E .

KIDNEY INTERNATIONAL, 1991, 39 (06) :1112-1117

[22] PROLONGED DIETARY-PROTEIN RESTRICTION IN DIABETIC NEPHROPATHY [J].

EVANOFF, G ;

THOMPSON, C ;

BROWN, J ;

WEINMAN, E .

ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (05) :1129-1133

[23] THE EFFECT OF DIETARY-PROTEIN RESTRICTION ON THE PROGRESSION OF DIABETIC NEPHROPATHY - A 12-MONTH FOLLOW-UP [J].

EVANOFF, GV ;

THOMPSON, CS ;

BROWN, J ;

WEINMAN, EJ .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :492-495

[24]

FELDTRASMUSSEN B, 1986, LANCET, V2, P1300

[25] EFFECT OF IMPROVED METABOLIC CONTROL ON LOSS OF KIDNEY-FUNCTION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS - AN UPDATE OF THE STENO STUDIES [J].

FELDTRASMUSSEN, B ;

MATHIESEN, ER ;

JENSEN, T ;

LAURITZEN, T ;

DECKERT, T .

DIABETOLOGIA, 1991, 34 (03) :164-170

[26] ANGIOTENSIN CONVERTING ENZYME-INHIBITORS VERSUS CALCIUM-ANTAGONISTS IN THE TREATMENT OF DIABETIC HYPERTENSIVE PATIENTS [J].

FERDER, L ;

DACCORDI, H ;

MARTELLO, M ;

PANZALIS, M ;

INSERRA, F .

HYPERTENSION, 1992, 19 (02) :237-242

[27] KIDNEY-DISEASE OF DIABETES-MELLITUS - NIDDK INITIATIVES FOR THE COMPREHENSIVE STUDY OF ITS NATURAL-HISTORY, PATHOGENESIS, AND PREVENTION [J].

FITZSIMMONS, SC ;

AGODOA, L ;

STRIKER, L ;

CONTI, F ;

STRIKER, G .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (01) :7-10

[28] REGRESSION OF MICROALBUMINURIA IN TYPE-II DIABETIC, HYPERTENSIVE PATIENTS AFTER LONG-TERM INDAPAMIDE TREATMENT [J].

GAMBARDELLA, S ;

FRONTONI, S ;

LALA, A ;

FELICI, MG ;

SPALLONE, V ;

SCOPPOLA, A ;

JACOANGELI, F ;

MENZINGER, G .

AMERICAN HEART JOURNAL, 1991, 122 (04) :1232-1238

[29] DIABETIC NEPHROPATHY - A CLINICAL AND PATHOLOGIC STUDY BASED ON RENAL BIOPSIES [J].

GELLMAN, DD ;

PIRANI, CL ;

SOOTHILL, JF ;

MUEHRCKE, RC ;

KARK, RM .

MEDICINE, 1959, 38 (04) :321-&

[30] LONG-TERM GLYCEMIC CONTROL AND THE RATE OF PROGRESSION OF EARLY DIABETIC KIDNEY-DISEASE [J].

GILBERT, RE ;

TSALAMANDRIS, C ;

BACH, LA ;

PANAGIOTOPOULOS, S ;

OBRIEN, RC ;

ALLEN, TJ ;

GOODALL, I ;

YOUNG, V ;

SEEMAN, E ;

MURRAY, RML ;

COOPER, ME ;

JERUMS, G .

KIDNEY INTERNATIONAL, 1993, 44 (04) :855-859

← 1 2 3 4 5 6 7 8 9 10 →